Discovery Lays the Foundation to Expand Personalized Chemotherapy for Leukemia Patients (St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center)
An international research team has determined how inherited gene variations lead to severe drug toxicity that may threaten chances for a cure in children with leukemia. St. Jude Children's Research Hospital scientists led the study, results of which set the stage to expand the use of a patient's genetic make-up to tailor chemotherapy.
St. Jude Children's Research Center/The University of Tennessee Health Science Center is one of the 26 NCCN Member Institutions.
...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Children | Genetics | Health | Hospitals | Leukemia | Science | Study | Toxicology